Newly growing evidence highlights the essential role that epitranscriptomic marks play in the
development of many cancers; however, little is known about the role and implications of …

Head and neck squamous cell carcinoma ranks seventh in incidence of malignant tumours
in the world. Although there are treatments including surgery, radiotherapy and …

Colorectal cancer (CRC) is the third most common cancer and has the second highest
mortality rate among cancers. The development of CRC involves both genetic and …

Background Indoleamine-2, 3-dioxygenase 1 (IDO1) is responsible for tumor immune
escape by regulating T cell-associated immune responses and promoting the activation of …

N6-Adenosine methylation, yielding N6-methyladenosine (m6A), is a reversible epigenetic
modification found in messenger RNAs and long non-coding RNAs (lncRNAs), which affects …

RNA modification has become an exciting underexplored field in recent years. In lung
adenocarcinoma (LUAD), m6A was the best characterized and most studied RNA …

Objectives This study aimed to investigate the mechanism of N6‐methyladenosine (m6A) in
the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) from periodontitis …

Abstract N6-methyladenosine (m6A), a posttranscriptional regulatory mechanism, is the
most common epigenetic modification in mammalian mRNA. M6A modifications play a …

Background Thyroid cancer (TC) is the most common endocrine malignancy worldwide, and
immunotherapy is a new cancer treatment that stimulates and enhances the natural ability of …

Background: Epigenetic regulations of immune responses are essential for cancer
development and growth. As a critical step, comprehensive and rigorous explorations of …